VERIGENE CYP2C19 NUCLEIC ACID TES (2C19)

Drug Metabolizing Enzyme Genotyping Systems

NANOSPHERE, INC

The following data is part of a premarket notification filed by Nanosphere, Inc with the FDA for Verigene Cyp2c19 Nucleic Acid Tes (2c19).

Pre-market Notification Details

Device IDK120466
510k NumberK120466
Device Name:VERIGENE CYP2C19 NUCLEIC ACID TES (2C19)
ClassificationDrug Metabolizing Enzyme Genotyping Systems
Applicant NANOSPHERE, INC 4088 COMMERCIAL AVENUE Northbrook,  IL  60062
ContactMark Del Vecchio
CorrespondentMark Del Vecchio
NANOSPHERE, INC 4088 COMMERCIAL AVENUE Northbrook,  IL  60062
Product CodeNTI  
CFR Regulation Number862.3360 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2012-02-15
Decision Date2012-11-06
Summary:summary

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.